Research menu
Jump to menu

Publications:  Dr Tahera Hussain

Gore ME, Griffin CL, Hancock B, Patel PM, Pyle L, Aitchison M, James N, Oliver RT et al.(2010). Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial. The Lancet vol. 375, (9715) 641-648.
Return to top